Mutations of APC and K-ras gene in aberrant crypt foci from human colon
10.3760/j.issn:0529-5807.2001.01.010
- VernacularTitle:结直肠粘膜隐窝异常病灶K-ras、APC基因突变的研究
- Author:
Ping YUAN
1
;
Menghong SUN
;
Jinsheng ZHANG
;
Xiongzeng ZHU
;
Daren SHI
Author Information
1. 皖南医学院
- From:
Chinese Journal of Pathology
2001;30(1):35-38
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the mutations of K-ras and APC gene in normal colorectal mucosa, aberrant crypt foci (ACF), adenoma and colorectal carcinoma(CRC); To study the genetic alteration in ACF and its possibility of being a molecular marker of very early colon cancer and to explore the relationship of ACF and colorectal adenoma. Methods DNA from 35 CRC, 15 adenomas, 34 ACF and 15 cases of normal mucosa with mucous glands were isolated by micro-dissection. Direct gene sequencing of k-ras gene including codon 12, 13 and 61 as well as the mutation cluster region (MCR) of APC gene. Results Mutation frequency of k-ras gene in ACF, adenoma and carcinoma was 17.6%(6/34), 13.3%(2/15), and 14.3%(5/35) respectively, showing no difference between the three pathologic changes. The ras gene mutation sites in adenomas, carcinomas and 4 ACF were limited to codon 12 (GGT→GAT), but in 2 ACF, they were located in codon 13 (GGC→GAC). K-ras gene mutation in ACF was found more frequently in old patients and in patients with polypoid cancers. No mutations were found in codon 61 in three types of tissue. Mutation rate of APC genes in adenomas and carcinomas was 22.9% (8/35) and 26.7%(4/15) respectively, which was higher than that of ACF 2.9%,(P<0.05). APC gene mutation in carcinomas was not correlated with age, location, size and differentiation. Conclusion The morphological changes and gene mutation status are different in ACF and adenomas. ACF is a very early morphological lesion in the carcinogenesis of colorectal carcinoma. Therefore, ACF is considered to be the putative “microadenoma” where the development of colorectal carcinomas may be from “normal epithelium to ACF and then to carcinomas”.
